MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana

Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Magenta Therapeutics, Inc. (NasdaqGM: MGTA) with Dianthus Therapeutics, Inc. pursuant to which Magenta shareholders are expected to own approximately 21.3% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([e-mail]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgm-mgta/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230503006126/en/

at the time of publication of the news with a fall of -15,76 % to 0,660 on Nasdaq stock exchange (04. Mai 2023, 02:00 Uhr).